Process Industries
Asahi Kasei Corp.
In the news
- Ventilator output ramps up as world braces for patient surge Mar 26, 2020
- Japan chemical makers to tap AI in joint materials project Feb 25, 2020
- Only 43% of Japanese companies to resume in China on Monday Feb 8, 2020
- Will your next car be made from paper and plastic? Dec 11, 2019
- Nobel boost: Battery stocks surge following Yoshino win Oct 11, 2019 See more articles on Asahi Kasei Corp.
Business Summary
Asahi Kasei Corp. operates as a holding company which provides monitoring, planning, and strategic management to its subsidiaries and affiliates. Its operations are carried out through the following segments: Materials, Homes, Health Care, and Others. The Materials segment includes caustic soda, chlorine, acrylonitrile, styrene, methyl methacrylate, adipic acid, polyethylene, polystyrene, and other petrochemicals. The Homes segment includes "Long Life Home" products and also provides remodeling, real estate, and urban redevelopment. The Health Care segment includes pharmaceuticals and diagnostic reagents. The Others segment includes engineering, employment agency and temporary staffing services. The company was founded on May 21, 1931 and is headquartered in Tokyo, Japan.
Financial Highlights
| Mar 2019 | JPY | USD |
| Revenue | 2,170.40B | 19,571.75M |
| Gross Profit | 715,748M | 6,454.30M |
| Operating income | 209,588M | 1,889.97M |
| Income before tax | 210,397M | 1,897.26M |
| Net income | 147,512M | 1,330.19M |
| EBITDA | 313,634M | 2,828.21M |
| Diluted EPS | 105.65 | 0.95 |
| Dividends Per Share | 34 | 0.30 |
| Total Assets | 2,575.20B | 23,266.05M |
| Total liabilities | 1,172.49B | 10,593.05M |
| Total equity | 1,381.48B | 12,481.23M |
| Operating cash flow | 212,062M | 1,912.28M |
| Currency in JPY | Currency in USD |
Historical Data
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | |
| Revenue | 1,986.40B | 1,940.91B | 1,882.99B | 2,042.21B | 2,170.40B |
| Gross Profit | 564,705M | 606,344M | 606,826M | 672,802M | 715,748M |
| Operating income | 157,933M | 165,203M | 159,230M | 198,475M | 209,588M |
| Income before tax | 158,440M | 146,389M | 157,388M | 218,333M | 210,397M |
| Net income | 105,652M | 91,754M | 115,000M | 170,249M | 147,512M |
| EBITDA | 253,311M | 274,835M | 268,423M | 311,938M | 313,634M |
| Diluted EPS | 75.62 | 65.69 | 82.34 | 121.92 | 105.65 |
| Dividends Per Share | 19 | 20 | 24 | 34 | 34 |
| Total Assets | 2,014.53B | 2,211.72B | 2,254.50B | 2,307.15B | 2,575.20B |
| Total liabilities | 916,809M | 1,154.33B | 1,086.38B | 1,001.93B | 1,172.49B |
| Total equity | 1,082.65B | 1,041.90B | 1,151.34B | 1,287.38B | 1,381.48B |
| Operating cash flow | 137,597M | 216,218M | 168,965M | 249,891M | 212,062M |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | |
| Revenue | 18,081.81M | 16,162.93M | 17,388.81M | 18,426.16M | 19,571.75M |
| Gross Profit | 5,140.38M | 5,049.32M | 5,603.84M | 6,070.44M | 6,454.30M |
| Operating income | 1,437.63M | 1,375.72M | 1,470.43M | 1,790.76M | 1,889.97M |
| Income before tax | 1,442.24M | 1,219.05M | 1,453.42M | 1,969.93M | 1,897.26M |
| Net income | 961.72M | 764.07M | 1,061.98M | 1,536.09M | 1,330.19M |
| EBITDA | 2,305.83M | 2,288.68M | 2,478.79M | 2,814.50M | 2,828.21M |
| Diluted EPS | 0.68 | 0.54 | 0.76 | 1.10 | 0.95 |
| Dividends Per Share | 0.17 | 0.16 | 0.22 | 0.30 | 0.30 |
| Total Assets | 16,798.25M | 19,678.17M | 20,232.43M | 21,693.96M | 23,266.05M |
| Total liabilities | 7,644.85M | 10,270.29M | 9,749.48M | 9,421.12M | 10,593.05M |
| Total equity | 9,027.75M | 9,269.99M | 10,332.44M | 12,105.18M | 12,481.23M |
| Operating cash flow | 1,252.51M | 1,800.55M | 1,560.33M | 2,254.67M | 1,912.28M |
Valuation Measures
| Mar 2019 | |
| PER | 10.80 |
| ROA | 6.04% |
| ROE | 11.05% |
| Operating margin | 9.65% |
| Profit margin | 6.79% |
Key executives
- Executive President & Representative Director: Hideki Kobori
- Director, Head-Information Technology & Finance: Yutaka Shibata
- General Manager-Research & Development: Hiroshi Shirai
- Head-Risk, Compliance, Legal & General Affairs: Nobuyuki Kakizawa
- Director & Executive Vice President: Hiroshi Yoshida
Shareholders
- Capital Research & Management Co. (World Investors) (8.4%)
- Nippon Life Insurance Co. (4.6%)
- Capital Research & Management Co. (Global Investors) (4.1%)
- Asset Management One Co., Ltd. (3.7%)
- Sumitomo Mitsui Trust Asset Management Co., Ltd. (3.2%)
- Nomura Asset Management Co., Ltd. (3.2%)
- BlackRock Fund Advisors (2.6%)
- The Vanguard Group, Inc. (2.5%)
- Asahi Kasei Employee Stock Ownership Plan (2.3%)
- Sumitomo Mitsui Financial Group, Inc. (1.8%)
Contact Details
- Website:http://www.asahi-kasei.co.jp
- Address: Hibiya Mitsui Tower, 1-1-2 Yuraku-cho, Tokyo, 100-0006, Japan
- Phone: +81.3.6699.3000
Related Companies
- Asahi Kasei Pharma Denmark A/S
- Asahikasei Haus SSI Co. Ltd.
- Polypore KK
- Asahi-Schwebel Co. Ltd.
- Asahi Kasei Plastics America, Inc.
- Asahi Kasei Corporate Venture Capital
- Asahi Kasei Board Incentive Plan
- Asahi-Schewebel Co., Ltd.
- Asahi Tokyo Investment Trust Management Co., Ltd.
- Asahi Kasei Europe GmbH
- Asahi Kasei (China) Investment Co. Ltd.
- Kyokuyo Textile (Thailand) Co. Ltd.
- Asahi Kasei Synthetic Rubber Europe NV/SA
- Asahi Kasei Deutschland GmbH
- Asahi Kasei E-Materials Korea, Inc.
- Asahi Kasei Medical Trading (Korea) Co. Ltd.
- Asahi Kasei Tibbi Cihazlar Tic Ltd. Sti
- Asahi Kasei (Suzhou) Plastics Compound Co. Ltd.
- Asahi Kasei EMD Taiwan Corp.
- Asahikasei Plastics (Hong Kong) Co. Ltd.
- Asahi Kasei Fibers Italia SRL
- Asahikasei Plastics (America), Inc.
- Asahi Kasei POM (Zhangjiagang) Co. Ltd.
- ASAHI KASEI MICROZA (Hangzhou) Co. Ltd.
- Asahi Kasei Bioprocess Europe NV/SA
- Asahi Kasei Medical Trading Taiwan Co. Ltd.
- Asahi Kasei Microdevices Korea Corp.
- Asahi Kasei Microdevices (Shanghai) Co. Ltd.
- Asahi Kasei Fibers International (Shanghai) Co. Ltd.
- Asahi Kasei Electronics Materials Changshu Co. Ltd.
Competitors
- Sumitomo Chemical Co., Ltd.
- Shen Ma Industry Co. Ltd. Class A
- Eternal Materials Co., Ltd.
- Covestro AG
- Chemours Co.
- LG Chem Ltd.
- Trinseo SA
- Fresenius Medical Care AG & Co. KGaA
- Green Seal Holding Ltd.
- Everspin Technologies, Inc.
- HC SemiTek Corp. Class A
- Shenzhen Capchem Technology Co., Ltd. Class A
- CytoSorbents Corporation
- Celanese Corporation
- Cirrus Logic, Inc.
- Nephros, Inc.
- PledPharma AB
- Stryker Corporation
Copyright © 2020 FactSet Research Systems Inc. All rights reserved.
Last Updated on 27 Mar, 2020